Sickle-cell/Hb-C disease without crisis
ICD-10 D57.20 is a billable code used to indicate a diagnosis of sickle-cell/hb-c disease without crisis.
Sickle-cell/Hb-C disease without crisis refers to a genetic blood disorder characterized by the presence of abnormal hemoglobin, specifically hemoglobin C, which can lead to hemolytic anemia. This condition arises from mutations in the HBB gene that encodes the beta-globin subunit of hemoglobin. Patients with Hb-C disease may experience chronic hemolytic anemia, splenomegaly, and increased susceptibility to infections. Unlike sickle cell crises, which involve acute pain episodes due to vaso-occlusive events, this code is used when the patient is not experiencing such crises. Management typically includes regular monitoring of hemoglobin levels, supportive care, and preventive measures against infections. Genetic counseling is often recommended for affected individuals and their families to understand inheritance patterns and implications for offspring. The clinical presentation can vary widely, and some patients may remain asymptomatic for extended periods, while others may have significant complications related to anemia and organ function.
Detailed lab results, genetic testing, and treatment plans.
Management of chronic anemia, monitoring for complications.
Ensure documentation reflects the absence of crisis and any related comorbidities.
Family history, genetic counseling notes, and test results.
Counseling patients about inheritance patterns and implications for family members.
Document genetic testing outcomes and recommendations for family screening.
Used to monitor hemoglobin levels and anemia status in patients with Hb-C disease.
Document the reason for the CBC and any relevant clinical findings.
Hematologists should ensure that all lab results are clearly linked to the diagnosis.
Sickle cell disease is characterized by the presence of hemoglobin S, while Hb-C disease involves hemoglobin C. Both conditions can lead to hemolytic anemia, but their genetic causes and clinical manifestations differ.
